RecruitingNCT06740929

Hormonal Management of Heavy Menstrual Bleeding in Adolescents

Hormonal Management of Heavy Menstrual Bleeding in Adolescents and Young Adults With and Without a Bleeding Disorder: a Prospective Observational Cohort Study


Sponsor

University Hospital, Geneva

Enrollment

163 participants

Start Date

Dec 17, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to evaluate whether hormonal medications (such as contraceptive pill, patch, injectable progestins and hormonal intra-uterine device) have similar efficacy at managing heavy menstrual bleeding in adolescents with a bleeding disorder compared to those without. We also aim to assess the quality of life and hemoglobin and iron levels in this population.


Eligibility

Sex: FEMALEMax Age: 25 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with bleeding disorder and heavy menstrual bleeding. The study is currently recruiting participants at 1 location. People eligible for this study include women up to age 25 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Geneva University Hospitals

Geneva, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06740929


Related Trials